Skip to Main Content

Paper Details

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.
JAMA Oncol
200
2017
Androgen, CD49f, KRT18, Luminal- and basal-like prostate cancers, NKX3, Participants, Prostate Cancer, androgen, androgen receptor, basal, basal prostate cancers, basal-like cancers, luminal, luminal A, luminal A prostate cancers, luminal B prostate cancers, luminal and basal lineage, luminal- and basal-like subtypes, luminal-like cancers, men, nonluminal B, patients, prostate cancer, prostate cancerspecific
Author NameAffiliation
Nicholas Erho
Mohammed Alshalalfa
Robert B DenSidney Kimmel Medical College at Thomas Jefferson University
Stephen J FreedlandCedars-Sinai Medical Center
Edwin M PosadasCedars-Sinai Medical Center
Howard M SandlerSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic
Scott A TomlinsUniversity of Michigan ann arbor
Scott A TomlinsMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanUniversity of Michigan ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute, University of Michigan ann arbor
Elai Davicioni
Ashley E RossJames Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions
Edward M SchaefferNorthwestern University
Paul L NguyenDana-Farber/Brigham and Women's Cancer Center, Harvard Medical School
Robert Jeffrey KarnesMayo Clinic
Daniel E SprattUniversity of Michigan ann arbor
Felix Y FengUniversity of Michigan ann arbor
Felix Y FengHelen Diller Comprehensive Cancer Center, University of California san francisco
Felix Y FengHelen Diller Comprehensive Cancer Center, University of California san francisco
Felix Y FengMichigan Center for Translational Pathology, University of Michigan ann arbor
Felix Y FengHelen Diller Comprehensive Cancer Center, University of California san francisco
  • 1 - 28

Datasets